Editorial Perspectives On Decentralized Trials

  1. GlobalData: COVID-19 Will Cause Clinical Trials To Sputter 3/27/2020

    The impact of the COVID-19 pandemic on clinical trials will be significant. A recent note from GlobalData shines a light on the impact COVID-19 will have on clinical trials. GlobalData interviewed 10 trial experts who noted the pandemic is already extensively impacting studies.

  2. Technology Advancements Spur Adoption Of Virtual Trials 1/17/2020

    Patient recruitment and retention in clinical trials has long been an issue for pharma companies. This results in many trials being delayed and even canceled. One recent advancement that could help with both recruitment and retention is virtual (decentralized) trials.

  3. Acquiring And Implementing Innovation In The Pharmaceutical Industry 12/5/2019

    Pravin Jadhav has spent his entire career in the world of drug development. He is currently the Senior Director of Applied Innovation at Otsuka. Jadhav was a featured speaker at the recent CNS Summit in Boca Raton, and we took that opportunity to talk to him about innovation in the pharmaceutical industry, and how companies can best acquire and implement new solutions. 

  4. What Exactly Is A Virtual Clinical Trial? 11/21/2019

    Oracle Health Sciences and the CNS Summit have released a research report on the use of virtual components (patient-facing technologies) in clinical trials. The findings are the result of focus group interviews and supplementary research with key stakeholders involved with clinical trials.

  5. Less Cumbersome Trials Will Reduce Clinical Costs & Timelines 10/28/2019

    Antony Loebel, president and CEO for Sunovion Pharmaceuticals, will be a featured speaker at the upcoming 2019 CNS Summit. In this Q&A, Loebel discusses CNS innovation, balancing the needs of clinical stakeholders, and the biggest changes we can expect over the next 10 years.

  6. Innovation Will Overcome Time & Cost Challenges Of Clinical Trials 10/18/2019

    Rob Scott, M.D., Chief Medical Officer and VP of Development for AbbVie, will be a featured speaker at the upcoming 2019 CNS Summit. In this Q&A, Scott discusses clinical innovation, patient voice, and the clinical challenges the pharmaceutical industry still needs to overcome.

  7. Is Your Clinical Trial Ready To Go Digital? 9/10/2019

    Digital clinical trials are a popular topic in the life sciences industry. But for all the talk we hear about the use of wearable devices in trials, it’s often hard to gauge exactly how many companies are using these devices.